PLX Company Profile and Key Details

Q: Who are the executives of PLX?

Ms. Yael FellousVice President of HRMr. Yaron NaosSenior Vice President of OperationsMr. Dror BashanPres, Chief Executive Officer & DirectorMr. Eyal Rubin M.B.A.Senior Vice President, Chief Financial Officer, Treasurer & Corporation Sec.

AMEX : PLX

Protalix BioTherapeutics

$2.06

At Close 4:00 PM

62.77

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Protalix BioTherapeutics, Inc. (PLX) stock declined over -1.94%, trading at $2.02 on AMEX, down from the previous close of $2.06. The stock opened at $2.03, fluctuating between $2.00 and $2.07 in the recent session.

Stock Snapshot

2.06

Prev. Close

162.75M

Market Cap

Day Low

10.63

P/E Ratio

0.19

EPS (TTM)

-0.03

Cash Flow per Share

2.03

Open

80.57M

Number of Shares

2.065

Day High

95.35%

Free Float in %

0.46

Book Value

564.99K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 16, 2026	2.07	2.09	2.05	2.06	228.22K
Jun 15, 2026	2.09	2.13	2.05	2.06	578.49K
Jun 12, 2026	2.07	2.11	2.06	2.09	249.05K
Jun 11, 2026	1.99	2.08	1.97	2.05	603.41K
Jun 10, 2026	1.98	2.01	1.96	1.97	360.83K
Jun 09, 2026	1.96	2.03	1.96	1.98	460.29K
Jun 08, 2026	1.97	2.02	1.95	1.96	454.66K
Jun 05, 2026	1.99	2.02	1.98	1.99	566.1K
Jun 04, 2026	1.96	2.02	1.95	2.01	597.09K
Jun 03, 2026	1.97	1.99	1.95	1.96	829.78K
Jun 01, 2026	2.10	2.12	2.05	2.06	555.07K
May 29, 2026	2.10	2.14	2.07	2.11	487.55K
May 28, 2026	2.10	2.19	2.10	2.10	704.41K
May 27, 2026	2.09	2.17	2.09	2.12	1.12M
May 26, 2026	2.14	2.16	2.10	2.14	734.71K
May 22, 2026	2.03	2.12	2.03	2.10	714.02K
May 21, 2026	1.98	2.07	1.98	2.03	873.55K
May 20, 2026	1.90	2.03	1.90	2.01	700.92K
May 19, 2026	1.91	1.99	1.88	1.90	743.21K
May 18, 2026	2.01	2.05	1.90	1.91	1.1M

Contact Details

Hackensack, NJ 07601

United States

https://www.protalix.com 201 696 9345

About Company

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in the last stage of clinical trials for the treatment of Fabry diseases; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Funda��o Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is based in Hackensack, New Jersey.

Stock Peers

TBXU

0.13+0.44%

Direxion Daily Biotech Top 5 Bull 2X ETF$29.86 PTHS

1.52+5.74%

Pelthos Therapeutics Inc.$28.02 PTN

-0.63-5.04%

Palatin Technologies, Inc.$11.87 AGE

-1.5-11.90%

AgeX Therapeutics, Inc.$11.10 CYBN

0.1+1.22%

Cybin Inc.$8.28 ARMP

-0.12-1.74%

Armata Pharmaceuticals, Inc.$6.79 NRXS

-0.09-1.32%

NeurAxis, Inc.$6.71 NSRX

-0.08-2.54%

Nasus Pharma Ltd.$3.07 CANF

0.01+0.33%

Can-Fite BioPharma Ltd.$3.00 SER

0.13+6.81%

Serina Therapeutics, Inc.$2.04

Frequently Asked Questions

What is the current Protalix BioTherapeutics, Inc. (PLX) stock price?

Protalix BioTherapeutics, Inc. (AMEX: PLX) stock price is $2.02 in the last trading session. During the trading session, PLX stock reached the peak price of $2.07 while $2.00 was the lowest point it dropped to. The percentage change in PLX stock occurred in the recent session was -1.94% while the dollar amount for the price change in PLX stock was - $0.04.

PLX's industry and sector of operation?

The AMEX listed PLX is part of Biotechnology industry that operates in the broader Healthcare sector. Protalix BioTherapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PLX?

Ms. Yael Fellous
Vice President of HR
Mr. Yaron Naos
Senior Vice President of Operations
Mr. Dror Bashan
Pres, Chief Executive Officer & Director
Mr. Eyal Rubin M.B.A.
Senior Vice President, Chief Financial Officer, Treasurer & Corporation Sec.

How PLX did perform over past 52-week?

PLX's closing price is 56.06% higher than its 52-week low of $1.32 where as its distance from 52-week high of $3.19 is -35.42%.

How many employees does PLX have?

Number of PLX employees currently stands at 213.

Link for PLX official website?

Official Website of PLX is: https://www.protalix.com

How do I contact PLX?

PLX could be contacted at phone 201 696 9345 and can also be accessed through its website. PLX operates from 2 University Plaza, Hackensack, NJ 07601, United States.

How many shares of PLX are traded daily?

PLX stock volume for the day was 564.99K shares. The average number of PLX shares traded daily for last 3 months was 807.69K.

What is the market cap of PLX currently?

The market value of PLX currently stands at $162.75M with its latest stock price at $2.02 and 80.57M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	213
Beta	-0.23
Sales or Revenue	$65.49M
5Y Sales Change%	-0.583%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	213
Beta	-0.23
Sales or Revenue	$65.49M
5Y Sales Change%	-0.583%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

PLX Company Profile and Key Details

Protalix BioTherapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Earnings & Analyst Outlook

Company Overview

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook